Concept explainers
Videos
To determine: The way by which the glucose concentration affects the insulin secretion of cells.
Introduction: Diabetes mellitus is a condition in the body that leads to
There are many foreign substances that act like activators and inhibitor molecules, which disrupt normal hormonal activities. One such chemical is Bisphenol A (BPA) that acts like natural estrogen hormone and have an endocrine disrupting and diabetogenic activity.
Explanation of Solution
BPA is a synthetic compound present in epoxy resins and plastics, such as food containers, beverage bottles, and so on. Using different studies, the researchers have found that BPA directly acts on the pancreatic cells and increases the risk of type 2 diabetes mellitus. BPA activates the estrogen receptor that presents in the pancreatic cells and disrupts the insulin secretion Diarylpropionitrile (DPN), which is a chemical that has similar effects as BPA. It can also bind and activate the estrogen receptor as BPA and affect the insulin secretion.
Refer Figure 34.11 “Effects of BPA and DPN on glucose-stimulated insulin secretion” in the textbook. In the given experiment, researchers focused to determine the effects of BPA on insulin secretion. The human pancreatic cells were cultured and treated with BPA and DPN. Later, the cells were monitored for the insulin secretion. The cells that were exposed to glucose alone, without the treatment with BPA and DPN, secreted less insulin when compared to the treated ones. DPN treated pancreatic cells produced two times more than the insulin and those cells with BPA treatment secreted three times more than the insulin than that of the cells that were exposed to glucose alone.
BPA treated pancreatic cells produced three times more than the insulin, DPN treated cells secreted two times more than the insulin when compared to the cells that were only exposed to glucose.
Want to see more full solutions like this?
Chapter 34 Solutions
Biology: The Unity and Diversity of Life (MindTap Course List)
- Bodybuilders use a variety of anabolic substances to gain mass. Two such compounds are insulin and trenbolone. Insulin has significant anabolic and anti-catabolic properties and impacts the metabolism of various macromolecules, not just that of carbohydrates. Trenbolone binds the androgen receptor with an affinity five times higher than that of testosterone and is popular for its fat-burning and anabolic properties. H. Trenbolone C18H2202 Insulin C257H383NosO77S6 How do the different targets, mechanisms of action and durations of each drug ultimately lead to the same desired effect (increase in lean body mass)?arrow_forwardDiabetes often results in the production of reduced levels of insulin. Researchers claim that a drug that binds to and blocks the active site of GSK3 might mimic the role of insulin in the pathway shown in Figure 2. Provide reasoning to justify the researchers' claim.arrow_forwardIn some forms of diabetes, a mutation in the b subunit of the insulin receptor abolishes the enzymatic activity of that subunit. How does the mutation affect the cell’s response to insulin? Can additional insulin (e.g., from injections) overcome the defect?arrow_forward
- Overexpression of this receptor in the cells of the adrenal gland causes Cushing's syndrome, a disease caused by the overproduction of cortisol. One strategy that scientists have employed to treat this disease is the use of small molecules that bind to, but do not activate, MC2R. This type of molecule is generically referred to as an antagonist. How can an antagonist bind to the same receptor as ACTH but not activate it? O a. The antagonist can bind covalently while ACTH binds non-covalently O b. The antagonist is only partially complimentary to the binding pocket of MC2R O The antagonist binds to ACTH and blocks it from binding to the receptor properly O d. The antagonist is the exact same structure as ACTH but since it is synthetic it doesn't work One cause of Cushing's syndrome is the inappropriate production of GPCRS in the adrenal gland that are not normally present in those cells. When these receptors are activated they result in the production of cortisol. Which statement about…arrow_forwardIn muscle cells, when adrenaline binds to beta-adrenergic receptor, it trigger signaling cascade leading to active glycogen phosphorylate breaks up glycogen into glucose subunits (Glycogen -> G1P). Base on following figure, describe this signaling cascade:arrow_forwardHuman growth hormone binds to a cell-surface membrane protein that is not a receptor tyrosine kinase. The intracellular domain of the receptor can bind other proteins inside the cell. Furthermore, studies indicate that the receptor is monomeric in the absence of hormone but dimerizes on hormone binding. Propose a possible mechanism for growth-hormone signaling.arrow_forward
- Suppose that you had a monoclonal antibody that recognized phosphotyros- ine. How would you expect that antibody to affect insulin signaling?arrow_forwardThe physiological effects of epinephrine should in principle be mimicked by addition of cAMP to the target cells. In practice, addition of cAMP to intact target cells elicits only a minimal physiological response. Why? When the structurally related derivative dibutyryl cAMP (shown below) is added to intact cells, the expected physiological response is readily apparent. Explain the basis for the difference in cellular response to these two substances. Dibutyryl cAMP is widely used in studies of cAMP function.arrow_forwardHbA1c is used to monitor blood glucose levels because hemoglobin is the only protein in blood that is covalently modified by glucose. True False Insulin Glargine is a long-acting form of insulin that is synthesized with several D-amino acids that slow its proteolytic degradation and extend the half-life of the insulin Glargine molecule. True Falsearrow_forward
- Novolog differs from "normal" insulin in that: Select one: a. An aspartic acid has been substituted for proline at B28 b. The proline at B28 and the lysine at B29 have been reversed c. A glycine has been substituten in at A21, and two new arginines have been added as B31 and B32 d. A "C-peptide" chain has been added e. The usual insulin molecule has been combined with zinc isophanearrow_forwardOne such laboratory study investigated the binding of a hormone to three different receptor proteins in the cell membrane. The data collected are shown in the table below: 1) Provide a brief explanation as to why ligand binding to proteins must be a reversible process. 2) Calculate the dissociation constant (Kd) for the hormone binding to each of the three proteins. 3) Which of the proteins demonstrate the tightest/strongest binding of the hormone? Which demonstrates the least tight binding of the hormone? What is the basis for your answer?arrow_forwardWhat kind of protein is the reactor in insulin signaling pathway: a ligand-gated channel, a G protein-linked receptor, or an enzyme- linked receptor? The receptor activates a specific kind of protein, Based on what that protein does, what is it called?arrow_forward
Human Physiology: From Cells to Systems (MindTap ...BiologyISBN:9781285866932Author:Lauralee SherwoodPublisher:Cengage Learning